Suppr超能文献

CXCL11 通过 CXCR3/ERK1/2 信号促进 α2δ1 肝肿瘤起始细胞的自我更新和致瘤性。

CXCL11 promotes self-renewal and tumorigenicity of α2δ1 liver tumor-initiating cells through CXCR3/ERK1/2 signaling.

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Cell Biology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Cell Biology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

出版信息

Cancer Lett. 2019 May 1;449:163-171. doi: 10.1016/j.canlet.2019.02.016. Epub 2019 Feb 13.

Abstract

Tumor-initiating cells (TICs), which are responsible for sustaining tumor growth and recurrence, rely on several regulatory factors. However, the mechanism of inflammation-related molecules in the acquisition and maintenance of TIC properties in hepatocellular carcinoma (HCC) remains elusive. We previously demonstrated that the voltage-gated calcium channel α2δ1 subunit is a functional surface marker of HCC TICs. Here, we found that the expression of an inflammation-related molecule C-X-C motif chemokine 11 (CXCL11) was significantly upregulated in α2δ1 HCC TICs and that CXCL11 induced the expression of stem cell-related genes, such as BMI1, NANOG, MDR1, ABCG2, and CACNA2D1. Furthermore, CXCL11 could promote the acquisition and maintenance of self-renewal, tumorigenic, and chemoresistance properties of α2δ1 HCC TICs by activating the extracellular signal-regulated kinase (ERK1/2) through its affinity receptor CXCR3. Collectively, our results suggest that CXCL11 may positively regulate the stemness of α2δ1 HCC TICs via ERK1/2 activation through an autocrine signaling pathway.

摘要

肿瘤起始细胞(TICs)是维持肿瘤生长和复发的关键,其依赖于几种调节因子。然而,炎症相关分子在肝癌(HCC)中 TIC 特性获得和维持中的作用机制仍不清楚。我们之前的研究表明,电压门控钙通道 α2δ1 亚基是 HCC TIC 的功能性表面标志物。在这里,我们发现炎症相关分子 C-X-C 基序趋化因子 11(CXCL11)在 α2δ1 HCC TIC 中表达显著上调,并且 CXCL11 诱导与干细胞相关的基因表达,如 BMI1、NANOG、MDR1、ABCG2 和 CACNA2D1。此外,CXCL11 可以通过其亲和受体 CXCR3 激活细胞外信号调节激酶(ERK1/2),从而促进 α2δ1 HCC TIC 自我更新、致瘤和化疗耐药特性的获得和维持。综上所述,我们的研究结果表明,CXCL11 可能通过自分泌信号通路通过激活 ERK1/2 正向调节 α2δ1 HCC TIC 的干性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验